# IGIP

## Overview
The IGIP gene encodes the IgA-inducing protein, a pivotal component in the immune system, particularly in the regulation of immunoglobulin A (IgA) production. This protein is primarily secreted by dendritic cells and is instrumental in facilitating the class switch recombination of B cells, enabling them to produce IgA antibodies. IgA is the predominant antibody isotype in mucosal secretions, playing a critical role in mucosal immunity by providing a frontline defense against pathogens. The IgA-inducing protein is categorized as a regulatory protein due to its involvement in enhancing IgA secretion, especially under conditions where the classical IgA switch factor, transforming growth factor-beta (TGF-β), is inadequate. Its activity is contingent upon a secondary signal from CD40, highlighting its involvement in both T-cell-dependent and T-cell-independent pathways of IgA production (Estes2010Regulation; Cáceres2021Development; Brandtzaeg2010Function).

## Structure


## Function
The IgA-inducing protein (IGIP) is a key regulator of immunoglobulin A (IgA) production, particularly in mucosal tissues. IGIP is secreted by dendritic cells and plays a crucial role in the class switch recombination of B cells to produce IgA antibodies. This process is essential for maintaining mucosal immunity, as IgA is the primary antibody isotype found in mucosal secretions, providing a first line of defense against pathogens (Cáceres2021Development; Brandtzaeg2010Function).

IGIP functions by enhancing IgA secretion from B cells, especially when the classical IgA switch factor, transforming growth factor-beta (TGF-β), is insufficient. It requires a secondary signal from CD40 for its activity, indicating its role in both T-cell-dependent and T-cell-independent pathways of IgA production (Estes2010Regulation; Cáceres2021Development). IGIP expression is upregulated by vasoactive intestinal peptide (VIP), linking neuropeptide signaling to immune responses in the gut (Estes2010Regulation; Pabst2012New).

Incorporating IGIP into live attenuated influenza virus vaccines has been explored to enhance mucosal and systemic immune responses, demonstrating its potential as a natural adjuvant (Cáceres2021Development).


## References


[1. (Estes2010Regulation) D. Mark Estes. Regulation of iga responses in cattle, humans and mice. Veterinary Immunology and Immunopathology, 138(4):312–317, December 2010. URL: http://dx.doi.org/10.1016/j.vetimm.2010.10.009, doi:10.1016/j.vetimm.2010.10.009. This article has 21 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.vetimm.2010.10.009)

[2. (Cáceres2021Development) C. Joaquín Cáceres, Stivalis Cardenas-Garcia, Aarti Jain, L. Claire Gay, Silvia Carnaccini, Brittany Seibert, Lucas M. Ferreri, Ginger Geiger, Algimantas Jasinskas, Rie Nakajima, Daniela S. Rajao, Irina Isakova-Sivak, Larisa Rudenko, Amy L. Vincent, D. Huw Davies, and Daniel R. Perez. Development of a novel live attenuated influenza a virus vaccine encoding the iga-inducing protein. Vaccines, 9(7):703, June 2021. URL: http://dx.doi.org/10.3390/vaccines9070703, doi:10.3390/vaccines9070703. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/vaccines9070703)

[3. (Pabst2012New) Oliver Pabst. New concepts in the generation and functions of iga. Nature Reviews Immunology, 12(12):821–832, October 2012. URL: http://dx.doi.org/10.1038/nri3322, doi:10.1038/nri3322. This article has 506 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nri3322)

[4. (Brandtzaeg2010Function) Per Brandtzaeg. Function of mucosa-associated lymphoid tissue in antibody formation. Immunological Investigations, 39(4–5):303–355, January 2010. URL: http://dx.doi.org/10.3109/08820131003680369, doi:10.3109/08820131003680369. This article has 173 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/08820131003680369)